{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:36:32Z","timestamp":1787160992307,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.bbrep.2021.101030","type":"journal-article","created":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T05:30:34Z","timestamp":1621920634000},"page":"101030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2985-6753","authenticated-orcid":false,"given":"Azza M.","family":"Elamir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfat G.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed HM.","family":"El-Komy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Mahmoud sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesreen M.","family":"Aboraia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2021.101030_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3899\/jrheum.090227","article-title":"Psoriasis induced or aggravated by drugs","volume":"83","author":"Rongioletti","year":"2009","journal-title":"J. Rheumatol. Suppl."},{"issue":"22","key":"10.1016\/j.bbrep.2021.101030_bib2","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4\u20135","key":"10.1016\/j.bbrep.2021.101030_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","article-title":"Diagnosis and classification of psoriasis","volume":"13","author":"Raychaudhuri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrep.2021.101030_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3389\/fimmu.2018.01533","article-title":"Long non-coding RNAs play a role in the pathogenesis of psoriatic arthritis by regulating MicroRNAs and genes involved in inflammation and metabolic syndrome","volume":"9","author":"Dolcino","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2021.101030_bib5","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3892\/mmr.2017.6532","article-title":"MALAT1 participates in ultraviolet B-induced photo-aging via regulation of the ERK\/MAPK signaling pathway","volume":"15","author":"Lei","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"44","key":"10.1016\/j.bbrep.2021.101030_bib6","doi-asserted-by":"crossref","first-page":"77400","DOI":"10.18632\/oncotarget.20490","article-title":"Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"issue":"28","key":"10.1016\/j.bbrep.2021.101030_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.32607\/20758251-2016-8-1-21-33","article-title":"MicroRNAs: the role in autoimmune inflammation","volume":"8","author":"Baulina","year":"2016","journal-title":"ACTA NATURAE"},{"key":"10.1016\/j.bbrep.2021.101030_bib8","first-page":"1497","article-title":"The Grainy head transcription factor Grhl3\/Get1, suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1","author":"Ambica","year":"2013","journal-title":"NIH Public Access"},{"key":"10.1016\/j.bbrep.2021.101030_bib9","first-page":"1","article-title":"MicroRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus","volume":"3","author":"E1","year":"2013","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101030_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/jsre.2000.5909","article-title":"Percentage of burned body surface area determination in obese and nonobese patients","volume":"91","author":"Livingston","year":"2000","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101030_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020279","article-title":"International Psoriasis Council. Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis","volume":"6","author":"Wittkowski","year":"2011","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bbrep.2021.101030_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.12266","article-title":"A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis","volume":"169","author":"Ports","year":"2013","journal-title":"Br J Dermatol. Jul"},{"key":"10.1016\/j.bbrep.2021.101030_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2021.101030_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101030_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra","year":"2015","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.bbrep.2021.101030_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.molmed.2014.09.002","article-title":"Long non-coding RNAs and control of gene expression in the immune system","volume":"20","author":"Atianand","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrep.2021.101030_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1189\/jlb.1RU0814-369R","article-title":"MicroRNAs function in CD8\u00feT cell biology","volume":"97","author":"Liang","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2021.101030_bib18","first-page":"277","article-title":"MiR-9-5p and miR-106a-5p dysregulated in CD4+ T-cells of multiple sclerosis patients and targeted essential factors of T helper17\/regulatory T-cells differentiation","volume":"21","author":"Majd","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.bbrep.2021.101030_bib19","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O'Connell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"13","key":"10.1016\/j.bbrep.2021.101030_bib20","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1073\/pnas.0810909106","article-title":"Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to pro inflammatory signals","volume":"106","author":"Bazzoni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrep.2021.101030_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/onc.2009.302","article-title":"Downregulation of E-cadherin is an essential event in activating beta-catenin\/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrep.2021.101030_bib22","first-page":"1","article-title":"Long non\u2010coding RNAs in rheumatoid arthritis","volume":"51","author":"Zheng","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/j.bbrep.2021.101030_bib23","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1873-3468.12315","article-title":"The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-\u0198B","volume":"590","author":"Gui","year":"2016","journal-title":"Federation of European Biochemical Societies (FEBS)"},{"issue":"2","key":"10.1016\/j.bbrep.2021.101030_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bbrep.2021.101030_bib25","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/jcmm.12576","article-title":"Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells","volume":"19","author":"Puthanveetil","year":"2015","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.bbrep.2021.101030_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jid.2016.11.022","article-title":"IL-6 differs from TNF-\u03b1: unpredicted clinical effects caused by IL-6 blockade in psoriasis","volume":"137","author":"Blauvelt","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.bbrep.2021.101030_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/0394632016662475","article-title":"Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-\u03b3 in psoriatic patients","volume":"29","author":"Rasheed","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbrep.2021.101030_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.autrev.2006.10.001","article-title":"Gender and autoimmunity","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bbrep.2021.101030_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2011.03.003","article-title":"Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms","volume":"234","author":"Greer","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.bbrep.2021.101030_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"Alonso","year":"2008","journal-title":"Neurology"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580821001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:53:24Z","timestamp":1762502004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580821001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":30,"alternative-id":["S2405580821001242"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101030","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-283734\/v1","asserted-by":"object"}]},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2021.101030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101030"}}